Skip to main content

Table 2 Multivariate adjusted hazard ratio for death in nasopharyngeal cancer patients (n = 3605)

From: The impact of time factors on overall survival in patients with nasopharyngeal carcinoma: a population-based study

 

Events/total (%)

Adjusted hazard ratiod

95 % CIc

p value

Wait time and duration of RTb

   

0.053

 Wait time ≤ 4 weeks, duration of RT ≤ 10 weeks

223/1946 (11.5)

1

  

 Wait time > 4 weeks, duration of RT ≤ 10 weeks

75/255 (29.4)

1.26

(0.95–1.67)

0.097

 Wait time ≤ 4 weeks, duration of RT > 10 weeks

177/1342 (13.2)

1.04

(0.85–1.27)

0.683

 Wait time > 4 weeks, duration of RT > 10 weeks

24/62 (38.7)

1.70

(1.10–2.60)

0.015

Hospital ownership

   

0.183

 For profit

135/1127 (12.0)

1

  

 Non-profit

273/1915 (14.3)

1.13

(0.91–1.40)

0.238

 Public

91/563 (16.2)

1.28

(0.98–1.67)

0.069

Hospital teaching level

   

0.552

 Medical center

313/2332 (13.4)

1

  

 Regional

162/1121 (14.5)

1.11

(0.91–1.36)

0.278

 District

24/152 (15.8)

1.01

(0.66–1.55)

0.948

Gender

    

 Male

387/2711 (14.3)

1

  

 Female

112/894 (12.5)

0.98

(0.79–1.22)

0.900

Age group

   

<0.001

 0–44.99 years

108/1239 (8.7)

1

  

 45–64.99 years

240/1916 (12.5)

1.25

(0.99–1.58)

0.052

 More than 65 years

151/450 (33.6)

2.65

(2.01–3.49)

<0.001

Treatment

    

 CCRTa

356/2970 (12.0)

1

  

 RTb alone

143/635 (22.5)

1.58

(1.26–1.98)

<0.001

Charlson Comorbidity Index Score (mean = 0.3778)

    

 Lower than mean

104/2597 (4.0)

1

  

 Higher than mean

395/1008 (39.2)

15.34

(12.26–19.18)

<0.001

Urbanization

   

0.598

 Urban

138/1149 (12.0)

1

  

 Suburban

198/1508 (13.1)

0.90

(0.72–1.12)

0.374

 Rural

163/948 (17.2)

0.89

(0.70–1.13)

0.372

  1. a CCRT concurrent chemoradiotherapy, b RT, radiotherapy
  2. c95 % CI, 95 % confidence interval
  3. dAdjusted for patient age, wait time, length of radiotherapy, gender, treatment, urbanization, Charlson Comorbidity Index Score, and hospital characteristics